-
1
-
-
61549132662
-
Mastocytosis
-
IARC Press, Lyon (France), S. Swerdlow, E. Campo, N.L. Harris (Eds.)
-
Horny H.P., Metcalfe D.D., Bennett J.M., et al. Mastocytosis. World Health Organization (WHO) classification of tumours. Pathology & genetics: tumours of haematopoietic and lymphoid tissues 2008, 54-63. IARC Press, Lyon (France). S. Swerdlow, E. Campo, N.L. Harris (Eds.).
-
(2008)
World Health Organization (WHO) classification of tumours. Pathology & genetics: tumours of haematopoietic and lymphoid tissues
, pp. 54-63
-
-
Horny, H.P.1
Metcalfe, D.D.2
Bennett, J.M.3
-
2
-
-
0026073372
-
Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells
-
Kirshenbaum A.S., Kessler S.W., Goff J.P., et al. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. JImmunol 1991, 146(5):1410-1415.
-
(1991)
JImmunol
, vol.146
, Issue.5
, pp. 1410-1415
-
-
Kirshenbaum, A.S.1
Kessler, S.W.2
Goff, J.P.3
-
3
-
-
0033215406
-
Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13)
-
Kirshenbaum A.S., Goff J.P., Semere T., et al. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 1999, 94(7):2333-2342.
-
(1999)
Blood
, vol.94
, Issue.7
, pp. 2333-2342
-
-
Kirshenbaum, A.S.1
Goff, J.P.2
Semere, T.3
-
5
-
-
0028152595
-
Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population
-
Rottem M., Okada T., Goff J.P., et al. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population. Blood 1994, 84(8):2489-2496.
-
(1994)
Blood
, vol.84
, Issue.8
, pp. 2489-2496
-
-
Rottem, M.1
Okada, T.2
Goff, J.P.3
-
7
-
-
13044305857
-
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis
-
Longley B.J., Metcalfe D.D., Tharp M., et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999, 96(4):1609-1614.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, Issue.4
, pp. 1609-1614
-
-
Longley, B.J.1
Metcalfe, D.D.2
Tharp, M.3
-
8
-
-
34250796815
-
Mastocytosis: state of the art
-
Horny H.P., Sotlar K., Valent P. Mastocytosis: state of the art. Pathobiology 2007, 74(2):121-132.
-
(2007)
Pathobiology
, vol.74
, Issue.2
, pp. 121-132
-
-
Horny, H.P.1
Sotlar, K.2
Valent, P.3
-
9
-
-
79952336888
-
Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis
-
Wilson T.M., Maric I., Simakova O., et al. Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis. Haematologica 2011, 96(3):459-463.
-
(2011)
Haematologica
, vol.96
, Issue.3
, pp. 459-463
-
-
Wilson, T.M.1
Maric, I.2
Simakova, O.3
-
10
-
-
0037238684
-
Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene
-
Sundstrom M., Vliagoftis H., Karlberg P., et al. Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene. Immunology 2003, 108(1):89-97.
-
(2003)
Immunology
, vol.108
, Issue.1
, pp. 89-97
-
-
Sundstrom, M.1
Vliagoftis, H.2
Karlberg, P.3
-
11
-
-
33747343192
-
Diagnostic evaluation and classification of mastocytosis
-
Valent P. Diagnostic evaluation and classification of mastocytosis. Immunol Allergy Clin North Am 2006, 26(3):515-534.
-
(2006)
Immunol Allergy Clin North Am
, vol.26
, Issue.3
, pp. 515-534
-
-
Valent, P.1
-
12
-
-
34548272148
-
KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities
-
Maric I., Robyn J., Metcalfe D.D., et al. KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities. JAllergy Clin Immunol 2007, 120(3):680-687.
-
(2007)
JAllergy Clin Immunol
, vol.120
, Issue.3
, pp. 680-687
-
-
Maric, I.1
Robyn, J.2
Metcalfe, D.D.3
-
13
-
-
52249118345
-
Regulatory effects of histamine and histamine receptor expression in human allergic immune responses
-
Akdis C.A., Jutel M., Akdis M. Regulatory effects of histamine and histamine receptor expression in human allergic immune responses. Chem Immunol Allergy 2008, 94:67-82.
-
(2008)
Chem Immunol Allergy
, vol.94
, pp. 67-82
-
-
Akdis, C.A.1
Jutel, M.2
Akdis, M.3
-
14
-
-
79958843169
-
Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations
-
Castells M., Metcalfe D.D., Escribano L. Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations. Am J Clin Dermatol 2011, 12(4):259-270.
-
(2011)
Am J Clin Dermatol
, vol.12
, Issue.4
, pp. 259-270
-
-
Castells, M.1
Metcalfe, D.D.2
Escribano, L.3
-
15
-
-
4544357034
-
Systemic mastocytosis: current concepts and treatment advances
-
Tefferi A., Pardanani A. Systemic mastocytosis: current concepts and treatment advances. Curr Hematol Rep 2004, 3(3):197-202.
-
(2004)
Curr Hematol Rep
, vol.3
, Issue.3
, pp. 197-202
-
-
Tefferi, A.1
Pardanani, A.2
-
16
-
-
33646051264
-
Current options in the treatment of mast cell mediator-related symptoms in mastocytosis
-
Escribano L., Akin C., Castells M., et al. Current options in the treatment of mast cell mediator-related symptoms in mastocytosis. Inflamm Allergy Drug Targets 2006, 5(1):61-77.
-
(2006)
Inflamm Allergy Drug Targets
, vol.5
, Issue.1
, pp. 61-77
-
-
Escribano, L.1
Akin, C.2
Castells, M.3
-
17
-
-
0000124580
-
The natural course of urticaria pigmentosa. Analysis and follow-up of 112 cases
-
Caplan R.M. The natural course of urticaria pigmentosa. Analysis and follow-up of 112 cases. Arch Dermatol 1963, 87:146-157.
-
(1963)
Arch Dermatol
, vol.87
, pp. 146-157
-
-
Caplan, R.M.1
-
18
-
-
34249333084
-
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria
-
Valent P., Akin C., Escribano L., et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007, 37(6):435-453.
-
(2007)
Eur J Clin Invest
, vol.37
, Issue.6
, pp. 435-453
-
-
Valent, P.1
Akin, C.2
Escribano, L.3
-
19
-
-
0037380382
-
Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology
-
Brockow K., Akin C., Huber M., et al. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology. JAm Acad Dermatol 2003, 48(4):508-516.
-
(2003)
JAm Acad Dermatol
, vol.48
, Issue.4
, pp. 508-516
-
-
Brockow, K.1
Akin, C.2
Huber, M.3
-
20
-
-
0036280010
-
Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease
-
Brockow K., Scott L.M., Worobec A.S., et al. Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease. Arch Dermatol 2002, 138(6):785-790.
-
(2002)
Arch Dermatol
, vol.138
, Issue.6
, pp. 785-790
-
-
Brockow, K.1
Scott, L.M.2
Worobec, A.S.3
-
21
-
-
0034994550
-
Clinical and histopathological aspects of cutaneous mastocytosis
-
Wolff K., Komar M., Petzelbauer P. Clinical and histopathological aspects of cutaneous mastocytosis. Leuk Res 2001, 25(7):519-528.
-
(2001)
Leuk Res
, vol.25
, Issue.7
, pp. 519-528
-
-
Wolff, K.1
Komar, M.2
Petzelbauer, P.3
-
22
-
-
0023764931
-
Gastrointestinal dysfunction in systemic mastocytosis. A prospective study
-
Cherner J.A., Jensen R.T., Dubois A., et al. Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology 1988, 95(3):657-667.
-
(1988)
Gastroenterology
, vol.95
, Issue.3
, pp. 657-667
-
-
Cherner, J.A.1
Jensen, R.T.2
Dubois, A.3
-
23
-
-
84884904326
-
Gastrointestinal manifestations inmastocytosis: a study of 83 patients
-
866-873.e3
-
Sokol H., Georgin-Lavialle S., Canioni D., et al. Gastrointestinal manifestations inmastocytosis: a study of 83 patients. JAllergy Clin Immunol 2013, 132(4). 866-873.e3.
-
(2013)
JAllergy Clin Immunol
, vol.132
, Issue.4
-
-
Sokol, H.1
Georgin-Lavialle, S.2
Canioni, D.3
-
24
-
-
0025921179
-
Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital
-
[discussion: 13S-4S]
-
Horan R.F., Austen K.F. Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital. JInvest Dermatol 1991, 96(3):5S-13S. [discussion: 13S-4S].
-
(1991)
JInvest Dermatol
, vol.96
, Issue.3
-
-
Horan, R.F.1
Austen, K.F.2
-
25
-
-
0033946286
-
Gastrointestinal abnormalities and involvement in systemic mastocytosis
-
Jensen R.T. Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin North Am 2000, 14(3):579-623.
-
(2000)
Hematol Oncol Clin North Am
, vol.14
, Issue.3
, pp. 579-623
-
-
Jensen, R.T.1
-
26
-
-
0036204668
-
Cytogenetic and molecular genetic abnormalities in systemic mastocytosis
-
Gupta R., Bain B.J., Knight C.L. Cytogenetic and molecular genetic abnormalities in systemic mastocytosis. Acta Haematol 2002, 107(2):123-128.
-
(2002)
Acta Haematol
, vol.107
, Issue.2
, pp. 123-128
-
-
Gupta, R.1
Bain, B.J.2
Knight, C.L.3
-
27
-
-
0017293388
-
Gastrointestinal involvement in systemic mastocytosis
-
Ammann R.W., Vetter D., Deyhle P., et al. Gastrointestinal involvement in systemic mastocytosis. Gut 1976, 17(2):107-112.
-
(1976)
Gut
, vol.17
, Issue.2
, pp. 107-112
-
-
Ammann, R.W.1
Vetter, D.2
Deyhle, P.3
-
28
-
-
0014296264
-
Gastrointestinal lesions in mastocytosis
-
Clemett A.R., Fishbone G., Levine R.J., et al. Gastrointestinal lesions in mastocytosis. Am J Roentgenol Radium Ther Nucl Med 1968, 103(2):405-412.
-
(1968)
Am J Roentgenol Radium Ther Nucl Med
, vol.103
, Issue.2
, pp. 405-412
-
-
Clemett, A.R.1
Fishbone, G.2
Levine, R.J.3
-
29
-
-
0020052921
-
Anew syndrome of symptomatic cutaneous mastocytoma producing vasoactive intestinal polypeptide
-
Wesley J.R., Vinik A.I., O'Dorisio T.M., et al. Anew syndrome of symptomatic cutaneous mastocytoma producing vasoactive intestinal polypeptide. Gastroenterology 1982, 82(5 Pt 1):963-967.
-
(1982)
Gastroenterology
, vol.82
, Issue.5 PART 1
, pp. 963-967
-
-
Wesley, J.R.1
Vinik, A.I.2
O'Dorisio, T.M.3
-
31
-
-
48349113831
-
Case-control cohort study of patients' perceptions of disability in mastocytosis
-
Hermine O., Lortholary O., Leventhal P.S., et al. Case-control cohort study of patients' perceptions of disability in mastocytosis. PLoS One 2008, 3(5):e2266.
-
(2008)
PLoS One
, vol.3
, Issue.5
-
-
Hermine, O.1
Lortholary, O.2
Leventhal, P.S.3
-
32
-
-
61549092158
-
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels
-
Bonadonna P., Perbellini O., Passalacqua G., et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. JAllergy Clin Immunol 2009, 123(3):680-686.
-
(2009)
JAllergy Clin Immunol
, vol.123
, Issue.3
, pp. 680-686
-
-
Bonadonna, P.1
Perbellini, O.2
Passalacqua, G.3
-
33
-
-
0025953101
-
Effect of major axial skeleton trauma on preexisting lumbosacral spondylolisthesis
-
Floman Y., Margulies J.Y., Nyska M., et al. Effect of major axial skeleton trauma on preexisting lumbosacral spondylolisthesis. JSpinal Disord 1991, 4(3):353-358.
-
(1991)
JSpinal Disord
, vol.4
, Issue.3
, pp. 353-358
-
-
Floman, Y.1
Margulies, J.Y.2
Nyska, M.3
-
34
-
-
0024988912
-
Osteoporosis as the sole presentation of bone marrow mastocytosis
-
Lidor C., Frisch B., Gazit D., et al. Osteoporosis as the sole presentation of bone marrow mastocytosis. JBone Miner Res 1990, 5(8):871-876.
-
(1990)
JBone Miner Res
, vol.5
, Issue.8
, pp. 871-876
-
-
Lidor, C.1
Frisch, B.2
Gazit, D.3
-
35
-
-
71949131585
-
Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity
-
Rueff F., Przybilla B., Bilo M.B., et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. JAllergy Clin Immunol 2009, 124(5):1047-1054.
-
(2009)
JAllergy Clin Immunol
, vol.124
, Issue.5
, pp. 1047-1054
-
-
Rueff, F.1
Przybilla, B.2
Bilo, M.B.3
-
36
-
-
0023859217
-
Pathology of the lymph node and spleen in systemic mast cell disease
-
Travis W.D., Li C.Y. Pathology of the lymph node and spleen in systemic mast cell disease. Mod Pathol 1988, 1(1):4-14.
-
(1988)
Mod Pathol
, vol.1
, Issue.1
, pp. 4-14
-
-
Travis, W.D.1
Li, C.Y.2
-
37
-
-
0029143689
-
Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 cases
-
Mican J.M., Di Bisceglie A.M., Fong T.L., et al. Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 cases. Hepatology 1995, 22(4 Pt 1):1163-1170.
-
(1995)
Hepatology
, vol.22
, Issue.4 PART 1
, pp. 1163-1170
-
-
Mican, J.M.1
Di Bisceglie, A.M.2
Fong, T.L.3
-
38
-
-
0023741248
-
Asurvey of the number and distribution of mast cells in the skin of patients with mast cell disorders
-
Garriga M.M., Friedman M.M., Metcalfe D.D. Asurvey of the number and distribution of mast cells in the skin of patients with mast cell disorders. JAllergy Clin Immunol 1988, 82(3 Pt 1):425-432.
-
(1988)
JAllergy Clin Immunol
, vol.82
, Issue.3 PART 1
, pp. 425-432
-
-
Garriga, M.M.1
Friedman, M.M.2
Metcalfe, D.D.3
-
39
-
-
0023129616
-
Mast cell numbers in diffuse scleroderma
-
Nishioka K., Kobayashi Y., Katayama I., et al. Mast cell numbers in diffuse scleroderma. Arch Dermatol 1987, 123(2):205-208.
-
(1987)
Arch Dermatol
, vol.123
, Issue.2
, pp. 205-208
-
-
Nishioka, K.1
Kobayashi, Y.2
Katayama, I.3
-
40
-
-
0023024216
-
Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells
-
Elias J., Boss E., Kaplan A.P. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. JAllergy Clin Immunol 1986, 78(5 Pt 1):914-918.
-
(1986)
JAllergy Clin Immunol
, vol.78
, Issue.5 PART 1
, pp. 914-918
-
-
Elias, J.1
Boss, E.2
Kaplan, A.P.3
-
41
-
-
0022616445
-
Increase in skin mast cells following chronic house dust mite exposure
-
Mitchell E.B., Crow J., Williams G., et al. Increase in skin mast cells following chronic house dust mite exposure. Br J Dermatol 1986, 114(1):65-73.
-
(1986)
Br J Dermatol
, vol.114
, Issue.1
, pp. 65-73
-
-
Mitchell, E.B.1
Crow, J.2
Williams, G.3
-
42
-
-
77956153867
-
Mastocytosis-an update
-
[quiz: 712]
-
Amon U., Hartmann K., Horny H.P., et al. Mastocytosis-an update. JDtsch Dermatol Ges 2010, 8(9):695-711. [quiz: 712].
-
(2010)
JDtsch Dermatol Ges
, vol.8
, Issue.9
, pp. 695-711
-
-
Amon, U.1
Hartmann, K.2
Horny, H.P.3
-
43
-
-
20144389124
-
Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes
-
Florian S., Krauth M.T., Simonitsch-Klupp I., et al. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Int Arch Allergy Immunol 2005, 136(3):273-280.
-
(2005)
Int Arch Allergy Immunol
, vol.136
, Issue.3
, pp. 273-280
-
-
Florian, S.1
Krauth, M.T.2
Simonitsch-Klupp, I.3
-
44
-
-
37749039528
-
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients
-
Brockow K., Jofer C., Behrendt H., et al. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008, 63(2):226-232.
-
(2008)
Allergy
, vol.63
, Issue.2
, pp. 226-232
-
-
Brockow, K.1
Jofer, C.2
Behrendt, H.3
-
45
-
-
84859435404
-
Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion
-
Morgado J.M., Sanchez-Munoz L., Teodosio C.G., et al. Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion. Mod Pathol 2012, 25(4):516-521.
-
(2012)
Mod Pathol
, vol.25
, Issue.4
, pp. 516-521
-
-
Morgado, J.M.1
Sanchez-Munoz, L.2
Teodosio, C.G.3
-
46
-
-
37349073347
-
Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis
-
Hahn H.P., Hornick J.L. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis. Am J Surg Pathol 2007, 31(11):1669-1676.
-
(2007)
Am J Surg Pathol
, vol.31
, Issue.11
, pp. 1669-1676
-
-
Hahn, H.P.1
Hornick, J.L.2
-
47
-
-
0028881815
-
The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis
-
Schwartz L.B., Sakai K., Bradford T.R., et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. JClin Invest 1995, 96(6):2702-2710.
-
(1995)
JClin Invest
, vol.96
, Issue.6
, pp. 2702-2710
-
-
Schwartz, L.B.1
Sakai, K.2
Bradford, T.R.3
-
48
-
-
0033945410
-
Treatment of systemic mast cell disorders
-
vii
-
Worobec A.S. Treatment of systemic mast cell disorders. Hematol Oncol Clin North Am 2000, 14(3):659-687. vii.
-
(2000)
Hematol Oncol Clin North Am
, vol.14
, Issue.3
, pp. 659-687
-
-
Worobec, A.S.1
-
49
-
-
0025302361
-
Cromolyn sodium in the management of systemic mastocytosis
-
Horan R.F., Sheffer A.L., Austen K.F. Cromolyn sodium in the management of systemic mastocytosis. JAllergy Clin Immunol 1990, 85(5):852-855.
-
(1990)
JAllergy Clin Immunol
, vol.85
, Issue.5
, pp. 852-855
-
-
Horan, R.F.1
Sheffer, A.L.2
Austen, K.F.3
-
50
-
-
0020683503
-
Intervention with epinephrine in hypotension associated with mastocytosis
-
Turk J., Oates J.A., Roberts L.J. Intervention with epinephrine in hypotension associated with mastocytosis. JAllergy Clin Immunol 1983, 71(2):189-192.
-
(1983)
JAllergy Clin Immunol
, vol.71
, Issue.2
, pp. 189-192
-
-
Turk, J.1
Oates, J.A.2
Roberts, L.J.3
-
51
-
-
0030742614
-
Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis
-
Godt O., Proksch E., Streit V., et al. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. Dermatology 1997, 195(1):35-39.
-
(1997)
Dermatology
, vol.195
, Issue.1
, pp. 35-39
-
-
Godt, O.1
Proksch, E.2
Streit, V.3
-
52
-
-
0021990197
-
Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes
-
Czarnetzki B.M., Rosenbach T., Kolde G., et al. Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes. Arch Dermatol Res 1985, 277(2):105-113.
-
(1985)
Arch Dermatol Res
, vol.277
, Issue.2
, pp. 105-113
-
-
Czarnetzki, B.M.1
Rosenbach, T.2
Kolde, G.3
-
53
-
-
0025978296
-
Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids
-
Guzzo C., Lavker R., Roberts L.J., et al. Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids. Arch Dermatol 1991, 127(2):191-196.
-
(1991)
Arch Dermatol
, vol.127
, Issue.2
, pp. 191-196
-
-
Guzzo, C.1
Lavker, R.2
Roberts, L.J.3
-
54
-
-
0022343136
-
Treatment of urticaria pigmentosa with corticosteroids
-
Barton J., Lavker R.M., Schechter N.M., et al. Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol 1985, 121(12):1516-1523.
-
(1985)
Arch Dermatol
, vol.121
, Issue.12
, pp. 1516-1523
-
-
Barton, J.1
Lavker, R.M.2
Schechter, N.M.3
-
55
-
-
0023078845
-
Mastocytosis with malabsorption, myelofibrosis, and massive ascites
-
Reisberg I.R., Oyakawa S. Mastocytosis with malabsorption, myelofibrosis, and massive ascites. Am J Gastroenterol 1987, 82(1):54-60.
-
(1987)
Am J Gastroenterol
, vol.82
, Issue.1
, pp. 54-60
-
-
Reisberg, I.R.1
Oyakawa, S.2
-
56
-
-
0027983756
-
Aretrospective analysis of bone scan abnormalities in mastocytosis: correlation with disease category and prognosis
-
Chen C.C., Andrich M.P., Mican J.M., et al. Aretrospective analysis of bone scan abnormalities in mastocytosis: correlation with disease category and prognosis. JNucl Med 1994, 35(9):1471-1475.
-
(1994)
JNucl Med
, vol.35
, Issue.9
, pp. 1471-1475
-
-
Chen, C.C.1
Andrich, M.P.2
Mican, J.M.3
-
57
-
-
79960798350
-
Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis
-
Laroche M., Livideanu C., Paul C., et al. Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis. Am J Med 2011, 124(8):776-778.
-
(2011)
Am J Med
, vol.124
, Issue.8
, pp. 776-778
-
-
Laroche, M.1
Livideanu, C.2
Paul, C.3
-
58
-
-
84879372052
-
Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management
-
Pardanani A. Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management. Am J Hematol 2013, 88(7):612-624.
-
(2013)
Am J Hematol
, vol.88
, Issue.7
, pp. 612-624
-
-
Pardanani, A.1
-
59
-
-
0026570013
-
Response to interferon alfa-2b in a patient with systemic mastocytosis
-
Kluin-Nelemans H.C., Jansen J.H., Breukelman H., et al. Response to interferon alfa-2b in a patient with systemic mastocytosis. NEngl J Med 1992, 326(9):619-623.
-
(1992)
NEngl J Med
, vol.326
, Issue.9
, pp. 619-623
-
-
Kluin-Nelemans, H.C.1
Jansen, J.H.2
Breukelman, H.3
-
60
-
-
0031943841
-
Response of severe systemic mastocytosis to interferon alpha
-
Butterfield J.H. Response of severe systemic mastocytosis to interferon alpha. Br J Dermatol 1998, 138(3):489-495.
-
(1998)
Br J Dermatol
, vol.138
, Issue.3
, pp. 489-495
-
-
Butterfield, J.H.1
-
61
-
-
0345167915
-
Cladribine therapy for systemic mastocytosis
-
Kluin-Nelemans H.C., Oldhoff J.M., Van Doormaal J.J., et al. Cladribine therapy for systemic mastocytosis. Blood 2003, 102(13):4270-4276.
-
(2003)
Blood
, vol.102
, Issue.13
, pp. 4270-4276
-
-
Kluin-Nelemans, H.C.1
Oldhoff, J.M.2
Van Doormaal, J.J.3
-
62
-
-
73349111582
-
Cytoreductive therapy in 108 adults with systemic mastocytosis: outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine
-
Lim K.H., Pardanani A., Butterfield J.H., et al. Cytoreductive therapy in 108 adults with systemic mastocytosis: outcome analysis and response prediction during treatment with interferon-alpha, hydroxyurea, imatinib mesylate or 2-chlorodeoxyadenosine. Am J Hematol 2009, 84(12):790-794.
-
(2009)
Am J Hematol
, vol.84
, Issue.12
, pp. 790-794
-
-
Lim, K.H.1
Pardanani, A.2
Butterfield, J.H.3
-
63
-
-
68649118339
-
Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis
-
Vega-Ruiz A., Cortes J.E., Sever M., et al. Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis. Leuk Res 2009, 33(11):1481-1484.
-
(2009)
Leuk Res
, vol.33
, Issue.11
, pp. 1481-1484
-
-
Vega-Ruiz, A.1
Cortes, J.E.2
Sever, M.3
-
64
-
-
33645687784
-
Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis
-
Shah N.P., Lee F.Y., Luo R., et al. Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis. Blood 2006, 108(1):286-291.
-
(2006)
Blood
, vol.108
, Issue.1
, pp. 286-291
-
-
Shah, N.P.1
Lee, F.Y.2
Luo, R.3
-
65
-
-
10744228486
-
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
-
Pardanani A., Ketterling R.P., Brockman S.R., et al. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood 2003, 102(9):3093-3096.
-
(2003)
Blood
, vol.102
, Issue.9
, pp. 3093-3096
-
-
Pardanani, A.1
Ketterling, R.P.2
Brockman, S.R.3
-
66
-
-
27144506215
-
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
-
Gotlib J., Berube C., Growney J.D., et al. Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood 2005, 106(8):2865-2870.
-
(2005)
Blood
, vol.106
, Issue.8
, pp. 2865-2870
-
-
Gotlib, J.1
Berube, C.2
Growney, J.D.3
-
67
-
-
78649504351
-
Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study
-
Paul C., Sans B., Suarez F., et al. Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study. Am J Hematol 2010, 85(12):921-925.
-
(2010)
Am J Hematol
, vol.85
, Issue.12
, pp. 921-925
-
-
Paul, C.1
Sans, B.2
Suarez, F.3
-
68
-
-
54349097778
-
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis
-
Aichberger K.J., Sperr W.R., Gleixner K.V., et al. Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis. Eur J Clin Invest 2008, 38(11):869-873.
-
(2008)
Eur J Clin Invest
, vol.38
, Issue.11
, pp. 869-873
-
-
Aichberger, K.J.1
Sperr, W.R.2
Gleixner, K.V.3
-
69
-
-
32844466631
-
Apilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis
-
Nakamura R., Chakrabarti S., Akin C., et al. Apilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis. Bone Marrow Transplant 2006, 37(4):353-358.
-
(2006)
Bone Marrow Transplant
, vol.37
, Issue.4
, pp. 353-358
-
-
Nakamura, R.1
Chakrabarti, S.2
Akin, C.3
-
70
-
-
0025136860
-
Splenectomy in the management of systemic mast cell disease
-
Friedman B., Darling G., Norton J., et al. Splenectomy in the management of systemic mast cell disease. Surgery 1990, 107(1):94-100.
-
(1990)
Surgery
, vol.107
, Issue.1
, pp. 94-100
-
-
Friedman, B.1
Darling, G.2
Norton, J.3
-
71
-
-
2442566909
-
Cutaneous mastocytosis in children: a clinical analysis of 71 cases
-
Kiszewski A.E., Duran-Mckinster C., Orozco-Covarrubias L., et al. Cutaneous mastocytosis in children: a clinical analysis of 71 cases. JEur Acad Dermatol Venereol 2004, 18(3):285-290.
-
(2004)
JEur Acad Dermatol Venereol
, vol.18
, Issue.3
, pp. 285-290
-
-
Kiszewski, A.E.1
Duran-Mckinster, C.2
Orozco-Covarrubias, L.3
-
72
-
-
44849118922
-
Phenotypic and genotypic characteristics of mastocytosis according to the age of onset
-
Lanternier F., Cohen-Akenine A., Palmerini F., et al. Phenotypic and genotypic characteristics of mastocytosis according to the age of onset. PLoS One 2008, 3(4):e1906.
-
(2008)
PLoS One
, vol.3
, Issue.4
-
-
Lanternier, F.1
Cohen-Akenine, A.2
Palmerini, F.3
-
73
-
-
18744387717
-
Pediatric cutaneous mastocytosis: a review of 180 patients
-
Ben-Amitai D., Metzker A., Cohen H.A. Pediatric cutaneous mastocytosis: a review of 180 patients. Isr Med Assoc J 2005, 7(5):320-322.
-
(2005)
Isr Med Assoc J
, vol.7
, Issue.5
, pp. 320-322
-
-
Ben-Amitai, D.1
Metzker, A.2
Cohen, H.A.3
-
74
-
-
84867294846
-
Systemic mastocytosis with associated acute myeloid leukemia with t (8; 21) (q22; q22)
-
Gadage V.S., Kadam Amare P.S., Galani K.S., et al. Systemic mastocytosis with associated acute myeloid leukemia with t (8; 21) (q22; q22). Indian J Pathol Microbiol 2012, 55(3):409-412.
-
(2012)
Indian J Pathol Microbiol
, vol.55
, Issue.3
, pp. 409-412
-
-
Gadage, V.S.1
Kadam Amare, P.S.2
Galani, K.S.3
-
75
-
-
80455158048
-
Myelomastocytic leukemia with t(8;21) in a 3-year-old child
-
Intzes S., Wiersma S., Meyerson H.J. Myelomastocytic leukemia with t(8;21) in a 3-year-old child. JPediatr Hematol Oncol 2011, 33(8):e372-e375.
-
(2011)
JPediatr Hematol Oncol
, vol.33
, Issue.8
-
-
Intzes, S.1
Wiersma, S.2
Meyerson, H.J.3
-
76
-
-
34249985527
-
Aggressive systemic mastocytosis after germ cell tumor of the ovary: C-KIT mutation documentation in both disease states
-
Lee J.W., Yang W.S., Chung S.Y., et al. Aggressive systemic mastocytosis after germ cell tumor of the ovary: C-KIT mutation documentation in both disease states. JPediatr Hematol Oncol 2007, 29(6):412-415.
-
(2007)
JPediatr Hematol Oncol
, vol.29
, Issue.6
, pp. 412-415
-
-
Lee, J.W.1
Yang, W.S.2
Chung, S.Y.3
-
77
-
-
79961181551
-
Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia
-
Mahadeo K.M., Wolgast L., McMahon C., et al. Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia. Pediatr Blood Cancer 2011, 57(4):684-687.
-
(2011)
Pediatr Blood Cancer
, vol.57
, Issue.4
, pp. 684-687
-
-
Mahadeo, K.M.1
Wolgast, L.2
McMahon, C.3
|